Related Experiment Video
Updated: Oct 12, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Opportunities to enhance antibiotic stewardship: colistin use and outcomes in a low-resource setting
Muhammad S Moolla1,2, Andrew Whitelaw3,4, Eric H Decloedt5
1Division of General Medicine, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa.
Background:
Colistin use is increasing with the rise in MDR Gram-negative infections globally. Effective antibiotic stewardship is essential to preserve this antibiotic of last resort.
Objectives:
This study investigated stewardship and safety errors related to colistin use to identify opportunities for improvement.
Patients And Methods:
A prospective descriptive study involving all patients 13 years and older treated with colistin at a tertiary hospital in Cape Town, South Africa, between August 2018 and June 2019. We collected clinical, laboratory and outcome data and assessed provided treatment for stewardship and safety errors.
Results:
We included 44 patients. Treatment errors were identified for 34 (77%) patients (median = 1), most commonly inadequate monitoring of renal function (N = 16, 32%). We also identified no rational indication for colistin (N = 9, 20%), loading dose error (N = 12, 27%); maintenance dose error (N = 10, 23%); no prior culture (N = 11, 25%); and failure to de-escalate (2 of 9) or adjust dose to changes in renal function (6 of 15). All cause in-hospital mortality was 47%. Amongst survivors, median ICU stay was 6 days and hospital stay more than 30 days. Eight (18%) patients developed renal injury or failure during treatment. Three (7%) patients in this study were found to have colistin-resistant organisms including two prior to colistin exposure.
Conclusions:
This study has identified opportunities to enhance colistin stewardship and improve efficacy and safety of prescription. The appearance of colistin-resistant organisms reinforces the urgent need to ensure effective and appropriate use of colistin.
Insights
Colistin stewardship errors are common, affecting 77% of patients, particularly in renal function monitoring. This highlights the urgent need for improved colistin use to combat rising resistance.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Pharmacy
Background:
- Colistin use is rising globally due to multidrug-resistant Gram-negative infections.
- Effective antibiotic stewardship is crucial for preserving colistin as a last-resort antibiotic.
Purpose of the Study:
- To investigate stewardship and safety errors in colistin prescribing.
- To identify areas for improvement in colistin utilization.
Main Methods:
- Prospective descriptive study of patients aged 13+ treated with colistin.
- Data collected on clinical, laboratory, and outcome parameters.
- Assessment of colistin treatment for stewardship and safety errors.
Main Results:
- Treatment errors occurred in 77% of 44 patients, most frequently inadequate renal function monitoring (32%).
- Other errors included lack of rational indication (20%), incorrect loading/maintenance doses (27%/23%), and failure to de-escalate or adjust for renal function.
- In-hospital mortality was 47%, with 18% experiencing renal injury. Colistin-resistant organisms were found in 7% of patients.
Conclusions:
- Significant opportunities exist to enhance colistin stewardship and improve prescription safety and efficacy.
- The emergence of colistin resistance underscores the critical need for appropriate and effective colistin use.
More Related Videos
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
Urine Studies II: Urine Culture and Sensitivity Test
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antimicrobial Effectiveness

